Privia Health Group, Inc. (NASDAQ:PRVA) Stock Position Lowered by Principal Financial Group Inc.

Principal Financial Group Inc. trimmed its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 5.4% during the 4th quarter, HoldingsChannel reports. The firm owned 3,077,948 shares of the company’s stock after selling 174,389 shares during the quarter. Principal Financial Group Inc.’s holdings in Privia Health Group were worth $60,175,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Nordea Investment Management AB grew its holdings in shares of Privia Health Group by 33.1% during the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after buying an additional 86,910 shares in the last quarter. Victory Capital Management Inc. boosted its position in Privia Health Group by 402.9% during the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after acquiring an additional 143,446 shares during the period. Franklin Resources Inc. grew its stake in Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after acquiring an additional 28,480 shares in the last quarter. Barclays PLC increased its holdings in shares of Privia Health Group by 240.3% in the 3rd quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after purchasing an additional 158,188 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of Privia Health Group by 8.4% in the third quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after purchasing an additional 14,641 shares in the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Stock Up 1.8 %

Shares of NASDAQ PRVA opened at $25.50 on Thursday. The company has a market cap of $3.06 billion, a price-to-earnings ratio of 255.03, a price-to-earnings-growth ratio of 3.56 and a beta of 0.87. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $25.67. The firm’s 50-day simple moving average is $21.85 and its 200 day simple moving average is $20.33.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Needham & Company LLC assumed coverage on shares of Privia Health Group in a research note on Friday, January 10th. They issued a “buy” rating and a $25.00 price objective on the stock. Macquarie assumed coverage on shares of Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Barclays increased their target price on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Truist Financial lifted their target price on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, JPMorgan Chase & Co. upped their price target on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Two equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Privia Health Group has an average rating of “Buy” and a consensus target price of $24.94.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.